The Effects of Acute Erythropoietin on Hepcidin and Dietary Iron Absorption Following Military-relevant Exercise in Energy Deficit: Pilot Study
NCT07517562 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2026-04-08
Summary
Military personnel frequently experience declines in iron status during training and when in the field, which may compromise performance. The overall purpose of this study is to determine why the decline in iron status occurs and potential countermeasures. Participants will be given an acute dose of erythropoietin (EPO) or placebo and will complete a 90-minute load carriage exercise test. Prior to the main trial, this pilot study will determine the optimal approach to assess iron absorption following exercise (red blood cell incorporation or plasma isotope appearance), the percentage of iron incorporated into red blood cells with EPO compared to placebo, and the timing of the intervention.
Conditions
- Iron Absorption
Interventions
- OTHER
-
Exercise test
90-minute load carriage exercise test on a treadmill
Sponsors & Collaborators
-
Pennington Biomedical Research Center
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-09-01
- Primary Completion
- 2025-12-31
- Completion
- 2026-05-01
Countries
- United States
Study Locations
More Related Trials
-
Erythropoietin Alfa in Elderly Subjects With Unexplained Anemia
NCT00954486 ·Status: WITHDRAWN ·Phase: NA
-
Insulin Resistance and Substrate Metabolism After Acute Erythropoietin (EPO) Administration
NCT00793767 ·Status: COMPLETED ·Phase: NA
-
Identification of New Serum Markers for Detection of Abuse With Erythropoietin
NCT01320449 ·Status: COMPLETED ·Phase: NA
-
Predictors of Response to Iron and Erythropoietin Stimulating Agents
NCT03658876 ·Status: COMPLETED ·Phase: PHASE4
-
Iron Dosing Pilot Study Using Model Predictive Control
NCT03633656 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia
NCT00210795 ·Status: TERMINATED ·Phase: PHASE2
-
An Observational Study to Predict the Response of Erythropoietin Treatment in Participants With Cancer Related Anemia Receiving Chemotherapy
NCT01736215 ·Status: TERMINATED
-
Assess Functional Outcomes in Anemic, Critically Ill, Trauma Patients When Taking Epoetin Alfa
NCT00210626 ·Status: TERMINATED ·Phase: PHASE2
-
Erythropoietin and Platelet Activation Markers
NCT01392612 ·Status: COMPLETED ·Phase: PHASE4
-
CD71 in Dried Blood Spots in Healthy Males
NCT04073849 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Efficacy & Safety Study of Recombinant Human Erythropoietin -Alpha, in Patients With Anemia of Chronic Renal Failure
NCT00399269 ·Status: COMPLETED ·Phase: PHASE3
-
A First Human Study of a Ferroportin Antibody
NCT01330953 ·Status: COMPLETED ·Phase: PHASE1
-
The Benefits of a Preoperative Anemia Management Program
NCT01888003 ·Status: TERMINATED ·Phase: NA
-
A Single Ascending Study of IOP Injection in Patients With Iron Deficient Anemia
NCT03485053 ·Status: TERMINATED ·Phase: PHASE2
-
Erythropoietin to Improve Critical Care Patient Outcomes
NCT05080049 ·Status: UNKNOWN ·Phase: PHASE3
-
Pharmacokinetic/ Pharmacodynamic Study of Epoetin Alfa (PROCRIT) in Critically Ill Patients.
NCT00210756 ·Status: COMPLETED ·Phase: PHASE2
-
Erythropoiesis Stimulating Agents for Anemia Management in Egyptian Hemodialysis Patients
NCT05699109 ·Status: COMPLETED
-
Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial Infarction
NCT00367991 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Epogen and Venofer Dosing Management on Hemoglobin Stability
NCT01975844 ·Status: TERMINATED ·Phase: PHASE4
-
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
NCT00058331 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Chronic Anemia With Epoetin Alfa in Elderly
NCT00337441 ·Status: UNKNOWN ·Phase: PHASE2
-
Recombinant Human Erythropoietin Dose, Serum Adiponectin, and All-Cause Mortality in Patients Beginning Hemodialysis
NCT00457561 ·Status: COMPLETED
-
Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer
NCT00258440 ·Status: TERMINATED ·Phase: NA
-
High Dose IV Iron Plus ESA in Chemotherapy-induced Anemia
NCT05768997 ·Status: RECRUITING ·Phase: PHASE3
-
Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation
NCT03010579 ·Status: UNKNOWN ·Phase: PHASE4